Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Andrews

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
BMJ (Clinical Research Ed.)|July 24, 1993
NSAIDS in the postoperative period. Many factors threaten renal functionC A O'Callaghan, P A Andrews, C S Ogg
JAMA|November 2, 1994
Successful pregnancy in cystinosisP A Andrews, S H Sacks, W van't Hoff
Cancer Communications|January 1, 1990
The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cellsE J Katz, P A Andrews, S B Howell
European Journal of Cancer & Clinical Oncology|April 1, 1989
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsP A Andrews, M P Murphy, S B Howell
Progress in Clinical and Biological Research|January 1, 1986
Cellular resistance to platinating agents in ovarian carcinomaP A Andrews, M P Murphy, S B Howell
International Journal of Cancer|July 30, 1991
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B Howell
Cancer Research|December 1, 1985
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletionP A Andrews, M P Murphy, S B Howell
Transplantation|September 15, 1994
Local transcription of complement C3 in human allograft rejection. Evidence for a pathogenic role and correlation to histology and outcomeP A Andrews, A Pani, W Zhou, et al.
Lancet (London, England)|November 20, 1993
Endogenous complement C3 synthesis in immune complex nephritisS H Sacks, W Zhou, P A Andrews, et al.
Biochimica Et Biophysica Acta|May 29, 1995
The effects of terbium on the accumulation of cisplatin in human ovarian cancer cellsR G Canada, P A Andrews, K M Mack, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
BMJ (Clinical Research Ed.)|July 24, 1993
NSAIDS in the postoperative period. Many factors threaten renal functionC A O'Callaghan, P A Andrews, C S Ogg
JAMA|November 2, 1994
Successful pregnancy in cystinosisP A Andrews, S H Sacks, W van't Hoff
Cancer Communications|January 1, 1990
The effect of DNA polymerase inhibitors on the cytotoxicity of cisplatin in human ovarian carcinoma cellsE J Katz, P A Andrews, S B Howell
European Journal of Cancer & Clinical Oncology|April 1, 1989
Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsP A Andrews, M P Murphy, S B Howell
Progress in Clinical and Biological Research|January 1, 1986
Cellular resistance to platinating agents in ovarian carcinomaP A Andrews, M P Murphy, S B Howell
International Journal of Cancer|July 30, 1991
Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cellsS C Mann, P A Andrews, S B Howell
Cancer Research|December 1, 1985
Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletionP A Andrews, M P Murphy, S B Howell
Transplantation|September 15, 1994
Local transcription of complement C3 in human allograft rejection. Evidence for a pathogenic role and correlation to histology and outcomeP A Andrews, A Pani, W Zhou, et al.
Lancet (London, England)|November 20, 1993
Endogenous complement C3 synthesis in immune complex nephritisS H Sacks, W Zhou, P A Andrews, et al.
Biochimica Et Biophysica Acta|May 29, 1995
The effects of terbium on the accumulation of cisplatin in human ovarian cancer cellsR G Canada, P A Andrews, K M Mack, et al.
Pageof 13